鳥インフルエンザワクチン市場レポート：2030年までの動向、予測、競合分析

鳥インフルエンザワクチンの動向と予測

世界の鳥インフルエンザワクチン市場は、2024年から2030年までのCAGRが8.7%で、2030年までに推定22億米ドルに達すると予想されます。この市場の主な促進要因は、信頼性が高く効率的な家禽用ワクチンへのニーズの高まり、養鶏場での鳥インフルエンザ発生件数の増加、鳥インフルエンザに対する国民の意識向上に向けた政府の取り組みの活発化です。世界の鳥インフルエンザワクチン市場の将来は、ニワトリ、アヒル、ガチョウ、トルコ、ウズラの各市場における機会によって有望視されています。

• Lucintelの予測では、タイプ別ではH5が予測期間中に最も高い成長を遂げる見込みです。
• 用途別では鶏肉が最も高い成長が見込まれます。
• 地域別では、APACが予測期間中に最も高い成長が見込まれます。

鳥インフルエンザワクチン市場の戦略的成長機会

鳥インフルエンザワクチン市場は、市場の発展とともに、多くのアプリケーションが戦略的な役割を果たすようになると思われます。市場参入企業が市場のダイナミクスを利用し、鳥インフルエンザによって発生すると思われる課題に対処するためには、これらの用途を概念的に理解することが重要です。したがって、こうした機会を特定することは、技術革新と総合的な市場対応力を促進する上で極めて重要です。

• 商業用家禽：このカテゴリーでは、商業用家禽産業が依然として最大の成長産業です。生産性の向上とバイオセキュリティ対策の推進により、群れを危険にさらす可能性のある疾病を予防し、信頼できる供給を確保するための効率的なワクチン接種が求められています。
• 裏庭養鶏：裏庭養鶏への関心が高まっていることから、この成長セクターがワクチン接種を受ける機会があります。しかし、ワクチン接種の経済的選択肢を備えた優れた教育的取り組みが、この裏庭養鶏セクターを維持する可能性があります。
• 輸出市場：ワクチン製造産業は、特に養鶏産業が成長している新興経済国において、様々な注目すべき輸出市場を持っています。現地でのプレゼンスを高め、国際的に要求される安全基準の遵守を強化することで、市場シェアが拡大する可能性があります。
• 野鳥保護への取り組み：野生鳥獣管理のための管理戦略に適切に組み込むことで、ワクチンプログラムは、移入を減らすことにより、家禽と野鳥の間の生態学的バランスと生物多様性の保全に純粋に貢献することができます。
• 研究開発における学術協力：学術機関との研究開発協力は、ワクチン技術の革新的な解決策をもたらし、新たな鳥インフルエンザの脅威に直面した際に能力を最大限に発揮するのに役立つため、積極的に模索すべきです。

これらの動向は、鳥インフルエンザワクチン市場を変革しつつあり、すべての用途において戦略的方向性が必須であることを示しています。これらの成長要因を活用することで、養鶏が持続可能な未来を形作ることが可能になります。

鳥インフルエンザワクチン市場促進要因・課題

鳥インフルエンザワクチン市場には多くの原因・促進要因があり、直面している課題には技術的、経済的、規制的なものがあります。鳥インフルエンザの脅威に対応するワクチン開発と展開戦略の方向性を形作るものです。

鳥インフルエンザワクチン市場を牽引している要因は以下の通りである：

• 家禽類生産の成長：家禽生産量の増加：世界の家禽製品の需要の高まりにより、効果的なワクチン接種の生産量を増やす必要性が生じています。このことは、製造業者に責任感を与え、家禽の健康を確保するために製品の革新と進歩に向かわせる。
• ワクチン開発の進歩：ワクチン開発における進歩には、ワクチンの効率と生産性を向上させるmRNA技術などが含まれ、それによってより良い疾病管理と効率的なアウトブレイク制御が維持されます。
• 政府の関与と投資：疾病予防と国境のバイオセキュリティに対する政府の取り組みと投資がワクチンの研究開発を強化し、この市場を活性化させています。
• バイオセキュリティ意識の高まり：養鶏農家におけるバイオセキュリティの重要性に対する意識の高まりは、より健康的な家禽群を実現するための予防ワクチン戦略の採用を後押しし、その結果、経済的損失を削減します。
• 国際貿易要件：国際貿易における厳しい衛生規制は、広範な鳥類ワクチン接種プログラムを要求するため、市場要件を満たす鳥インフルエンザに対する効果的なワクチンが必要となります。

鳥インフルエンザワクチン市場における課題は以下のとおりです：

• 規制上の障壁：規制上の障壁：国内法の規制体制が複雑なため、ワクチンの承認や市場参入が遅れ、適切なワクチンの入手時期が妨げられることがあります。
• 経済的制約：新興経済諸国では、経済的な制約により、ワクチンを購入することができず、アクセスも困難な場合があります。
• ウイルス株の進化：鳥インフルエンザウイルスの絶え間ない変異は、ワクチンの有効性を複雑にしており、新たに出現した株に対して常に更新し、適応させる必要があります。

目次

第1章 エグゼクティブサマリー

第2章 世界の鳥インフルエンザワクチン市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の鳥インフルエンザワクチン市場の動向（2018～2023年）と予測（2024～2030年）
• 株タイプ別：世界の鳥インフルエンザワクチン市場
  • H5
  • H9
  • H7
  • その他
• タイプ別：世界の鳥インフルエンザワクチン市場
  • 不活性化
  • 生弱毒化
  • 組み換え
  • ベクターベース
  • その他
• 用途別：世界の鳥インフルエンザワクチン市場
  • チキン
  • アヒル
  • ガチョウ
  • ターキー
  • ウズラ
  • その他

第4章 2018年から2030年までの地域別市場動向と予測分析

• 地域別世界の鳥インフルエンザワクチン市場
• 北米の鳥インフルエンザワクチン市場
• 欧州の鳥インフルエンザワクチン市場
• アジア太平洋地域の鳥インフルエンザワクチン市場
• その他地域の鳥インフルエンザワクチン市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 株タイプ別の世界の鳥インフルエンザワクチン市場の成長機会
  • タイプ別の世界の鳥インフルエンザワクチン市場の成長機会
  • 用途別の世界の鳥インフルエンザワクチン市場の成長機会
  • 地域別の世界の鳥インフルエンザワクチン市場の成長機会
• 世界の鳥インフルエンザワクチン市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界の鳥インフルエンザワクチン市場の生産能力拡大
  • 世界の鳥インフルエンザワクチン市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Boehringer Ingelheim International
• Guangdong Wenshi Dahuanong Biotechnology
• Ceva
• Yebio Bioengineering
• Zoetis

Avian Influenza Vaccine Trends and Forecast

The future of the global avian influenza vaccine market looks promising with opportunities in the chicken, duck, goose, turkey, and quail markets. The global avian influenza vaccine market is expected to reach an estimated $2.2 billion by 2030 with a CAGR of 8.7% from 2024 to 2030. The major drivers for this market are increasing need for reliable and efficient poultry vaccines, growing number of avian influenza outbreaks in poultry farms, and increased government efforts towards public awareness of avian flu.

• Lucintel forecasts that, within the type category, H5 is expected to witness the highest growth over the forecast period.
• Within the application category, chicken is expected to witness the highest growth.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Avian Influenza Vaccine Market

Avian Influenza Vaccine market trends are easy to identify. They are increasingly driven by technical improvements as well as shifts in the regulatory environment. Country and industry actions to control avian influenza lead naturally to the need to know these trends for the development and delivery of effective vaccines. Trends represent a collective effort to increase the effectiveness and availability of vaccines in a rapidly changing disease environment.

• More R&D: More investments in research and development are aiding in innovative formulations and delivery mechanisms for vaccines, which, apart from making it more potent against newer strains, enhance better global biosecurity.
• More recombinant vaccines: They would be an essential requirement for poultry health and the least disturbing element in food chains. It will ensure a local immunity level with fewer side effects.
• Improved Regulatory Environments: Tough regulations are forcing manufacturers to work on higher standards of safety. Consequently, vaccines produced are both safe for animals and humans while being simultaneously effective.
• International Cooperation Programs: Governments, research institutions, and private organizations worldwide collaborate with their international counterparts, thus making collaborations stronger. International partners share knowledge and resources to ensure that the best approach is used in dealing with avian influenza.

These trends remake the Avian Influenza Vaccine market through innovation and improved global cooperation for better poultry health and food security. Capitalizing on strategies in keeping with these trends can help address the complexities associated with avian influenza management.

Recent Developments in the Avian Influenza Vaccine Market

Recent work on Avian Influenza Vaccine supports new strategies aimed at augmenting the efficacy and distribution of vaccines step by step. These innovations are truly part of a continuous fight against avian flu since the poultry sector is up against the most pressing threats to its health and economic stability worldwide. Innovation and collaboration speak to the urgency to act against avian influenza since it is an ongoing threat.

• Next-Generation Vaccines: Vaccine platforms using mRNA technologies could revolutionize the management of avian influenza because they could be used for quicker vaccine production and are targeted toward developing an appropriate immune response.
• Supply Chain Strengthening: The initiative to strengthen vaccine supply chain mechanisms ensures the availability of vaccines in a timely manner during outbreaks. The supply chain and storage mechanisms are well-supported logistics and vaccine management solutions that would ensure the maintenance of the integrity of vaccines from production to administration.
• Integration of Digital Technologies: The use of digital technologies to track and monitor the effectiveness of vaccines. In turn, the processing of results may be done in real time, and the response efforts made effective.
• Public Awareness Campaigns: Increased benefit of vaccination to farmers through heightened awareness campaigns. This results in better health and productivity of flocks due to increased uptake rates.
• International Collaboration with Organizations: Strategic partnerships will enable knowledge exchange and resource sharing with organizations, such as the FAO, that positively impacts global strategies in fighting avian influenza.

These developments greatly influence the Avian Influenza Vaccine market by enhancing the effectiveness and accessibility of vaccine delivery, thus improving disease management and protecting the poultry industry worldwide. The market will be well-positioned for sustainable growth and resilience in any future outbreak if issues like these are confronted head-on.

Strategic Growth Opportunities for Avian Influenza Vaccine Market

A number of applications will be strategic for the Avian Influenza Vaccine market in this regard as the market evolves. A conceptual understanding of these applications is critical for market participants looking to capitalize on market dynamics and address the challenges likely to be generated by avian influenza. The identification of these opportunities is, therefore, of prime importance in fostering innovation and total market responsiveness.

• Commercial Poultry: In this category, the commercial poultry industry is still the largest growth industry. The drive for higher productivity and biosecurity measures demands efficient vaccination in preventing diseases that may jeopardize flocks and ensure a reliable supply.
• Backyard Poultry: With increased interest in backyard poultry farming, there is an opportunity for access to vaccination by this growing sector; although good educational initiatives with economic options for vaccination may sustain this sector of backyard poultry farmers.
• Export Markets: The vaccine manufacturing industry has various notable export markets, especially in the emerging economies with growing poultry industries. The on-site presence can be increased there, and with increased observance of internationally required safety standards, market share might increase.
• Wild Bird Conservation Efforts: Properly assimilated into the control strategies for wildlife management, vaccine programs can genuinely help conserve the ecological balance and biodiversity between domestic and wild birds by reducing transfers.
• Academic Collaborations in Research and Development: Research and development collaborations with academic institutions should be sought actively, as they will result in innovative solutions for vaccine technologies and help maximize capabilities in the face of emerging avian influenza threats.

These trends are transforming the Avian Influenza Vaccine market and indicate that strategic direction is a must in all the applications, thus helping poultry health systems to be strong in their designs. Taking advantage of these growth factors would make it feasible to shape a future where poultry farming could be sustainable.

Avian Influenza Vaccine Market Driver and Challenges

There are many causes or drivers of the Avian Influenza Vaccine Market, and the challenges facing it include several technological, economic, and regulatory types. Understanding these dynamics is important for stakeholders navigating this landscape; they shape the direction of vaccine development and deployment strategies in response to avian influenza threats.

The factors responsible for driving the avian influenza vaccine market include:

• Growth in Poultry Production: Growing demand for poultry products worldwide creates the necessity of increasing the production of effective vaccination. This adds a sense of responsibility to manufacturers and directs them toward innovating and advancing their products to ensure the health of their flocks.
• Advancements in Vaccine Development: Advances in the development of vaccines encompass mRNA technology, among others, to increase the efficiency and productivity of vaccines, thereby maintaining better disease management and efficient control of outbreaks.
• Government Involvement and Investments: Government initiatives and investments in disease prevention and border biosecurity enhance research and development of vaccines, thus fueling this market.
• Growing Biosecurity Awareness: Increasing awareness among poultry farmers about the importance of biosecurity boosts the adoption of preventive vaccination strategies to achieve healthier flocks and therefore reduce economic losses.
• International Trade Requirements: Strict health regulations in international trade require a broad avian vaccination program, thus necessitating effective vaccines against avian influenza that meet market requirements.

Challenges in the avian influenza vaccine market include:

• Regulatory Barriers: The complexity of the regulatory regime within national legislation delays vaccine approvals and entry into the market, whereby the timing of the availability of appropriate vaccines can be impeded.
• Economic Limitations: In some developing economies, due to economic constraints, vaccines would be unaffordable and inaccessible; thus, large-scale vaccination programs would be affected.
• Evolution in Virus Strains: Continuous mutation in avian influenza viruses complicates the effectiveness of vaccines, necessitating constant updates and adaptations against newly reappearing strains.

The drivers and challenges powerfully impact the Avian Influenza Vaccine market, shaping some of the innovation strategies and confronting global concerns over poultry health. Only by understanding and responding to these factors will stakeholders in this crucial market navigate the complexities in this area. The ability to adapt to this dynamic will be crucial for long-term sustainability and effectiveness in managing avian influenza.

List of Avian Influenza Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies avian influenza vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the avian influenza vaccine companies profiled in this report include-

• Boehringer Ingelheim International
• Guangdong Wenshi Dahuanong Biotechnology
• Ceva
• Yebio Bioengineering
• Zoetis

Avian Influenza Vaccine by Segment

The study includes a forecast for the global avian influenza vaccine by strain type, type, application, and region.

Avian Influenza Vaccine Market by Strain Type [Analysis by Value from 2018 to 2030]:

• H5
• H9
• H7
• Others

Avian Influenza Vaccine Market by Type [Analysis by Value from 2018 to 2030]:

• Inactivated
• Live Attenuated
• Recombinant
• Vector-Based
• Others

Avian Influenza Vaccine Market by Application [Analysis by Value from 2018 to 2030]:

• Chicken
• Duck
• Goose
• Turkey
• Quail
• Others

Avian Influenza Vaccine Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Avian Influenza Vaccine Market

Advancements in the Avian Influenza Vaccine market are witnessing significant progress across all geographies, driven by outbreaks and the powerful need to improve biosecurity. However, the avian influenza threats loom large ahead for poultry health and the world's food supply, and a host of countries, including the U.S., China, Germany, India, and Japan, are working together to advance vaccine efficacy, streamline channels of distribution, and develop comprehensive surveillance networks. These initiatives don't only connect directly to immediate health issues but also contribute to long-term strategies for tackling avian flu outbreaks in different parts of the world.

• United States: The U.S. has increased its investment in vaccine research and joined forces with biotech companies to improve response mechanisms. Recently, approvals have been granted to new vaccine strains that promise better protection against rising H5N1 variants and enhanced biosecurity in poultry farms.
• China: Governmental innovation has allowed the vaccine market to flourish in China with new vaccines. Now, China is shifting focus toward recombinant vaccines that demonstrate efficiency and safety for effective production and cater to both domestic and international exports.
• Germany: With all the investments Germany has made through public-private partnerships into high-performance vaccines, new formulation and delivery technologies are awaited to enhance the immune response, particularly for commercial poultry sectors, which are likely to enhance food security and exports.
• India: Vaccination in India has gradually increased since the growth of the country's poultry industry. The government encourages local vaccine manufacturers to design cost-effective vaccines, and as a result, accessibility has increased, and biosecurity measures have strengthened against outbreaks of avian influenza.
• Japan: With the new developments in vaccine technology, Japan is engaging in international collaborations with research institutions. Among these are newly developed inactivated as well as live-attenuated vaccines that can protect both wild and domestic birds, thus addressing ecological and economic concerns.

Features of the Global Avian Influenza Vaccine Market

Market Size Estimates: Avian influenza vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Avian influenza vaccine market size by strain type, type, application, and region in terms of value ($B).

Regional Analysis: Avian influenza vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different strain types, types, applications, and regions for the avian influenza vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the avian influenza vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the avian influenza vaccine market by strain type (H5, H9, H7, and others), type (inactivated, live attenuated, recombinant, vector-based, and others), application (chicken, duck, goose, turkey, quail, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Avian Influenza Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Avian Influenza Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Avian Influenza Vaccine Market by Strain Type
  • 3.3.1: H5
  • 3.3.2: H9
  • 3.3.3: H7
  • 3.3.4: Others
• 3.4: Global Avian Influenza Vaccine Market by Type
  • 3.4.1: Inactivated
  • 3.4.2: Live Attenuated
  • 3.4.3: Recombinant
  • 3.4.4: Vector-Based
  • 3.4.5: Others
• 3.5: Global Avian Influenza Vaccine Market by Application
  • 3.5.1: Chicken
  • 3.5.2: Duck
  • 3.5.3: Goose
  • 3.5.4: Turkey
  • 3.5.5: Quail
  • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Avian Influenza Vaccine Market by Region
• 4.2: North American Avian Influenza Vaccine Market
  • 4.2.1: North American Avian Influenza Vaccine Market by Strain Type: H5, H9, H7, and Others
  • 4.2.2: North American Avian Influenza Vaccine Market by Application: Chicken, Duck, Goose, Turkey, Quail, and Others
• 4.3: European Avian Influenza Vaccine Market
  • 4.3.1: European Avian Influenza Vaccine Market by Strain Type: H5, H9, H7, and Others
  • 4.3.2: European Avian Influenza Vaccine Market by Application: Chicken, Duck, Goose, Turkey, Quail, and Others
• 4.4: APAC Avian Influenza Vaccine Market
  • 4.4.1: APAC Avian Influenza Vaccine Market by Strain Type: H5, H9, H7, and Others
  • 4.4.2: APAC Avian Influenza Vaccine Market by Application: Chicken, Duck, Goose, Turkey, Quail, and Others
• 4.5: ROW Avian Influenza Vaccine Market
  • 4.5.1: ROW Avian Influenza Vaccine Market by Strain Type: H5, H9, H7, and Others
  • 4.5.2: ROW Avian Influenza Vaccine Market by Application: Chicken, Duck, Goose, Turkey, Quail, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Avian Influenza Vaccine Market by Strain Type
  • 6.1.2: Growth Opportunities for the Global Avian Influenza Vaccine Market by Type
  • 6.1.3: Growth Opportunities for the Global Avian Influenza Vaccine Market by Application
  • 6.1.4: Growth Opportunities for the Global Avian Influenza Vaccine Market by Region
• 6.2: Emerging Trends in the Global Avian Influenza Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Avian Influenza Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Avian Influenza Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Boehringer Ingelheim International
• 7.2: Guangdong Wenshi Dahuanong Biotechnology
• 7.3: Ceva
• 7.4: Yebio Bioengineering
• 7.5: Zoetis